Home  /  News  /  Research and Innovation  / 

Desai Sethi Presents, Debates and Is Recognized at AUA 2023

It was a banner year for Desai Sethi Urology Institute of Miami Miller School of Medicine at urology’s premier meeting, the American Urological Association (AUA) 2023, held April 28-May 1 in Chicago.

Dr. Dipen Parekh speaking from podium at the plenary session
Dr. Dipen Parekh speaking at the plenary session

“At AUA2023, the institute’s faculty and researchers led and debated during plenary sessions and presented novel research in topics spanning prostate and bladder cancers to sexual function and robotic surgery. It was also a year of firsts. Studies by our investigators were selected as among the few to be published simultaneously the AUA’s flagship Journal of Urology. And for the first time, one of our patients was selected to speak at the AUA’s recently launched Patient Perspectives session,” said Desai Sethi Urology institute Chair and Founding Director Dipen J. Parekh, M.D., who spoke during the meeting’s plenary session, “Survivor Debate: Salvage Therapy for RT Failures: QOL and CS Outcomes with Surgery vs. Cryo/HIFU vs. ADT vs. Observation.”

When surveyed, the majority of audience members agreed with Dr. Parekh’s recommendation in favor of observation. “Salvage treatment in any form can be high risk and low benefits. First, do no harm,” said Dr. Parekh.

Sushruta Award

Dr. Parekh was honored with the 2023 Sushruta Award, a distinguished honor given annually to a member of the AUA affiliate organization Indian American Urological Association, which represents 600 Indian urologists practicing in the U.S. The award recognizes those who have made significant contributions to the field of medicine.

Broad Scope of Current Urology Research Presented

The scope of impactful research at the institute, the Miller School and Sylvester Comprehensive Cancer Center was a highlight of this year’s AUA experience, according to Sanoj Punnen, M.D., associate professor and vice chair of research, Desai Sethi Urology Institute and co-chair of the Genitourinary Site Disease Group at Sylvester.

Dr. Sanoj Punnen, Dr. Mark Gonzalgo and others at the Desai Sethi AUA reception
(From left) Dr. Sanoj Punnen; Dr. Michael Ahdoot of Cedars Sinai; Dr. Badrinath Konety of Allina Health; and Dr. Mark Gonzalgo at the Desai Sethi reception

“In less than two years since its beginning, the institute has notably advanced the science of urology. That’s evident given the high impact presentations and participation at AUA2023,” said Dr. Punnen, who led the project “4Kscore Predicts Progression on Active Surveillance for Prostate Cancer Independently of Clinical Information and PIRADS Score,” a poster presented by Jessica Delgado, PGY2 resident. The study found the blood-based biomarker 4Kscore predicts disease progression independently of clinical risk and MRI.

Dr. Chad Ritch at the AUA 2023 plenary session
Dr. Chad Ritch at the AUA 2023 plenary session

Sylvester researcher Chad R. Ritch, M.D., M.B.A., associate professor of urology at the Miller School, spoke during several sessions on bladder cancer, including in the plenary presentation “Second Opinion Cases: BCG Failure in Non-muscle Invasive Bladder Cancer (NMIBC).” Bacillus Calmette-Guerin (BCG) is a type of immunotherapy used to treat bladder cancer. Dr. Ritch also presented on bladder cancer treatment dilemmas and bladder cancer tumor markers.

Mark L. Gonzalgo, M.D., Ph.D., professor and vice chair of urology at the institute, moderated the “Bladder Cancer: Non-Invasive III” poster session and helped to select the abstracts and presentations featured during the session.

Dr. Mark Gonzalgo speaking at AUA Robotics Theatre 2023
Dr. Mark Gonzalgo speaking at AUA Robotics Theatre 2023

Dr. Gonzalgo shared new robotic techniques for prostate cancer during an AUA Robotics Theater, and was featured in a prostate cancer surgery video highlighting the latest surgical techniques for prostate cancer, presented by Desai Sethi urologic-oncology fellow Dinno Francis Mendiola, M.D.

“We highlighted factors that contribute to better outcomes related to urinary control after robotic surgery for prostate cancer,” Dr. Gonzalgo said.

Dr. Mendiola conducted a podium presentation, “Prostate Cancer Localized: Surgical Therapy III,” investigating whether a robotic approach to radical prostatectomy for prostate cancer would result in fewer men having urinary incontinence after surgery. Desai Sethi researchers found that early continence rates after the procedure, called Retzius-sparing robotic-assisted radical prostatectomy, were indeed encouraging, with the majority of men being completely dry or using zero to one pad per day within one week of catheter removal and by three months following surgery.

Desai Sethi Urology Institute fellow Ankur Malpani, M.D., presented during a Video Abstract Theater on Adrenal and Renal Oncology, on a complex kidney cancer case treated with robotic partial nephrectomy, which is the robotic approach to surgical removal of part of a kidney. This particular robotic approach, called circular nephrotomy, could be an option when kidney tumors are difficult to reach surgically.

Female Urology

Raveen Syan, M.D., assistant professor of clinical urology at the Desai Sethi Urology Institute, had several roles at the meeting, including as course co-director for the Indian AUA Annual Meeting and panelist during the debate topic “Implantable Tibial vs. SNM,” which compared implantable tibial nerve stimulation with sacral neuromodulation (SNM) for the treatment of pelvic floor disorders.

Dr. Raveen Syan, co-director of the IAUA annual meeting, speaking from podium
Dr. Raveen Syan, co-director of the IAUA annual meeting

Dr. Syan was the senior author for moderated poster sessions including “Pelvic Floor Disorders Among Minority Women: Differences in Prevalence and Severity Based on Race/Ethnicity and Healthcare Setting,” presented by Miller School medical student Nathalie Perez.

“We won best poster award for ‘Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine,’” Dr. Syan said.

Dr. Syan also was senior author for “Disparities in Awareness and Treatment-Seeking Behavior for Pelvic Floor Disorders Among Minority Women,” presented by medical student Caroline Shermoen; “Examining the Influence of Race and Pelvic Floor Disorder Severity on Health-Related Social Needs Among Minority Women,” presented by medical student Sajana Satish; and “Evaluating the Presence of Female Urologists in Top Urology Departments in the United States,” presented by Miller School resident Sabika Sadiq, D.O.

Dr. Syan also authored a poster along with senior author Katherine Amin, M.D., FRCSC assistant professor of female pelvic medicine and reconstructive surgery (FPMRS) at the Miller School, “Language-Related Disparities in Acute Postoperative Pain Management Following Pelvic Floor Reconstructive Surgery.” Presented by medical student Fatima Khan, the moderated poster presentation highlighted Dr. Amin’s work to understand native-language inequities.

Dr. Amin, who is assistant professor of clinical urology and FPMRS/urogynecology fellowship director, spoke at the Society of Academic Urology, giving an overview of the history of social media and how urologists can constructively implement it into their practice for promoting patient education and professional development.

In addition, Dr. Amin’s efforts were highlighted at the Society of Women in Urology (SWIU) meeting. She currently serves as task force chair for SWIU at AUA Sections, an initiative to host SWIU events at each of the eight AUA Annual Section Meetings to increase visibility, promote mentorship and encourage meaningful representation at the section level.

Urology and Sexual Health

On the topic of sexual function, Thomas Masterson, M.D., assistant professor of urology at the institute, took part in a plenary debate titled “Crossfire: Controversies in Urology: It Is Ethical to Charge for PRP, Shock Wave, and Stem Cell Therapy for Erectile Dysfunction,” in which he argued that it is reasonable to charge for safe and in-demand restorative therapies for erectile dysfunction. Dr. Masterson also presented on the rare but bothersome issue of painful nocturnal erections within the Sexual Medicine Society of North America agenda track.

Emad Ibrahim, M.D., director of the clinical andrology lab at the Desai Sethi Urology Institute and director of the Male Fertility Research Program at The Miami Project to Cure Paralysis, presented “Penile Vibratory Stimulation (PVS): The Method of Choice for Anejaculation after Spinal Cord Injury.”

“Spinal cord injury is the leading cause of the inability to ejaculate in young men. After spinal cord injury, 90% of these men will need a method of assisted ejaculation to achieve biological fatherhood, and penile vibratory stimulation is the gold standard for treating this condition,” said Dr. Ibrahim, who is also assistant professor of urology and neurological surgery at the Miller School. “Our video presentation during AUA taught attendees new skills and techniques for performing PVS to treat ejaculatory dysfunction in men with spinal cord injury.”

Dr. Ibrahim was awarded a $3.25 million grant by the Department of Defense for a four-year study on the use of an oral medication to treat an infertility issue that affects most men with spinal cord injury.

Patient Perspectives

AUA selected Reuben Samuels to participate in a “Patient Perspectives” program, designed to enhance patient-physician communications and shared decision making. Reuben shared his experience as a cystic fibrosis patient advocating for sexual health care in “Self-Advocacy for Sexual Health Concerns in Patients with Cystic Fibrosis.”

This was the second year of the Patient Perspectives program at AUA and the first time a patient from the Miller School was featured.

Other Desai Sethi researchers presenting at AUA2023 included:

  • Hemendra Shah, M.D., on the debate topic “Robotic Waterjet Ablation (Aquaablation) vs. HOLEp for BPH Treatment”
  • Himanshu Arora, Ph.D., “Exogenous Nitric Oxide, S-Nitrosylates the CSF1 Receptor to Sensitize the Castration-Resistant Prostate Cancer Cells to CSF1R Blockade”
  • Kajal Khodamoradi, Ph.D., “Androgen Receptor Signaling in the Human Penis Is Similar Regardless of Serum Testosterone Level”
  • Libert Ramos, D.N.P., M.S.N./Ed., APRN-C., “Utilization of APPs within the Contemporary Men’s Health Center: From Patient Assessment to Procedures and Bridging the Gap to Primary Care”
  • Shivank Bhatia, M.D., “Prostate Artery Embolization — Multicenter Retrospective Experience of 1,000 Patients with Short-, Mid-, and Long-Term Follow Up”

Tags: American Urological Association, bladder cancer, Brian Ledesma, Caroline Shermoen, Desai Sethi Urology Institute, Dr. Ankur Malpani, Dr. Chad Ritch, Dr. Dinno Francis Mendiola, Dr. Dipen J. Parekh, Dr. Dipen Parekh, Dr. Emad Ibrahim, Dr. Hemendra Shah, Dr. Himanshu Arora, Dr. Kajal Khodamoradi, Dr. Katherine Amin, Dr. Mark Gonzalgo, Dr. Raveen Syan, Dr. Sabika Sadiq, Dr. Sanoj Punnen, Dr. Shivank Bhatia, Dr. Thomas Masterson, erectile dysfunction, Fatima Khan, genitourinary, Gold Cytoscope Award, Jessica Delgado, Journal of Urology, Libert Ramos, pelvic floor dysfunction, prostate cancer, Reuben Samuels, Sajana Satish, sexual dysfunction, spinal cord injury, Sushruta Awards